 |
enasidenib |
|---|---|
| Trade Name | Idhifa |
| Orphan Indication | Acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2014-06-12 00:00:00 |
| Sponsor | Celgene Corporation;Corporate Woods Bldg 32, Suite 900, 9225 Indian Creek Parkway;Overland Park, Kansas, 66210 |
